Target ID:dt243
CID:4075
Compound Name:Mesalamine
Gene ID:240
Gene Name:ALOX5
Species:Homo sapiens (human)
PubMed IDs:--
Action:Inhibitor

Knowledge Graph

Target IDCIDCompound NameGene IDGene NameSpeciesAction
dt1141 54675783 Minocycline 240 ALOX5 Homo sapiens (human) Inhibitor Details
dt1286 135413496 Balsalazide Disodium 240 ALOX5 Homo sapiens (human) Arachidonate 5-lipoxygenase inhibitor Details
dt1326 5339 Sulfasalazine 240 ALOX5 Homo sapiens (human) Arachidonate 5-lipoxygenase inhibitor Details
dt1333 5339 Sulfasalazine 240 ALOX5 Homo sapiens (human) Inhibitor Details
dt467 14985 Alpha-Tocopherol 240 ALOX5 Homo sapiens (human) -- Details
dt524 54585 Balsalazide 240 ALOX5 Homo sapiens (human) Inhibitor Details
dt528 54585 Balsalazide 240 ALOX5 Homo sapiens (human) -- Details
dt730 5280492 Leukotriene B4 240 ALOX5 Homo sapiens (human) ALOX5 protein promotes the reaction [lipopolysaccharide, E. coli O26-B6 results in increased abundance of leukotriene b4]|zileuton inhibits the reaction [ALOX5 protein promotes the reaction [lipopolysaccharide, E. coli O26-B6 results in increased abundanc Details
dt731 5280492 Leukotriene B4 240 ALOX5 Homo sapiens (human) Quercetin 3-O-glucuronide inhibits the reaction [ALOX5 protein results in increased chemical synthesis of leukotriene b4]|quercetin 3'-sulfate inhibits the reaction [ALOX5 protein results in increased chemical synthesis of leukotriene b4]|luteolin inhibit Details
dt732 5280492 Leukotriene B4 240 ALOX5 Homo sapiens (human) ALOX5 protein results in increased secretion of leukotriene B4 Details

Drug IDDrug NameTypeDrugBank IDTargetsCategoryLatest Progress
Drug26 Mesalazine Chemical drug -- -- -- Under clinical trials Details

Compound IDSource IDSource TypeCompound NameMolecular WeightMolecular FormulaMolecular Species
No data available

Disease IDDisease NameDefinitionMechanism
No data available

Strategy IDTherapy StrategySynonymsRelated DrugsMechanism
No data available